CRV puts advanced bioengineering in its shopping basket

 CRV, an early-stage venture firm that made headlines last year for its stance on then-candidate Donald Trump’s campaign, is looking to get out a new (non-political) message: it’s diving more deeply into the business of AI-driven biotech. The move comes years after some other venture firms have taken a deep dive into biotech, including True Ventures and Andreessen Horowitz. But… Read More
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.